EEG-Based Brain-Computer Interface Project for Individuals With Amyotrophic Lateral Sclerosis (ALS)
Launched by DREXEL UNIVERSITY COLLEGE OF MEDICINE · Jul 16, 2008
Trial Information
Current as of June 22, 2025
Completed
Keywords
ClinConnect Summary
This study design requires that the individual live in the Philadelphia region. Please contact the Wadsworth Center of the New York State Department of Health and State University of New York at Albany directly if you reside outside of this area.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Medical Subjects:
- • Be able to give consent themselves or via a legally authorized representative.
- • Diagnosed with a neuromuscular disease and have limited ability to communicate.
- • Be able to see visual cues such as targets or letters presented on the screen, and/or ability to hear auditory cues such as tones or words presented through speakers or earphones.
- • Be able to understand and remember instructions concerning participation.
- Healthy control subjects:
- • Be able to consent to give consent themselves or via a legally authorized representative.
- • Be able to see visual cues such as targets or letters presented on the screen, and/or ability to hear auditory cues such as tones or words presented through speakers or earphones.
- • Be able to understand and remember instructions concerning participation.
- Exclusion Criteria:
- • Individuals with cognitive impairments that would impact their ability to follow the instructions
About Drexel University College Of Medicine
Drexel University College of Medicine is a prominent academic institution dedicated to advancing healthcare through innovative research and clinical trials. As a sponsor of clinical trials, the College leverages its extensive expertise in medical education and research to explore new therapeutic interventions and improve patient outcomes. Committed to fostering collaboration among multidisciplinary teams, Drexel University College of Medicine prioritizes ethical standards and regulatory compliance in its research endeavors, ensuring the safety and well-being of trial participants while contributing valuable insights to the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Trial Officials
Terry Heiman-Patterson, MD
Principal Investigator
MDA/ALS Center of Hope
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials